Evidence map›Paper›PMID 38309456›Full record

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2024

The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma.

Andrea S Wolf, Megan Eisele, Dorothy J Giroux, Ritu Gill, Anna K Nowak, Andrea Bille, David Rice, Robert T Ripley, Isabelle Opitz, Francoise Galateau-Salle and 5 more

Abstract read
In one paragraph

Article in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Pleural mesothelioma.Nature reviews. Disease primers · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Andrea S WolfDepartment of Thoracic Surgery, The Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: andrea.wolf@mountsinai.org.
Megan EiseleCancer Research And Biostatistics, Seattle, Washington.
Dorothy J GirouxCancer Research And Biostatistics, Seattle, Washington.
Ritu GillDepartment of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Anna K NowakMedical School of the University of Western Australia, Crawley, Western Australia, Australia.
Andrea BilleDepartment of Thoracic Surgery, Guy's Hospital, London, United Kingdom.
David RiceDepartment of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, Texas.
Robert T RipleyDivision of General Thoracic Surgery, Baylor College of Medicine, Houston, Texas.
Isabelle OpitzDepartment of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Francoise Galateau-SalleMESOPATH, MESOBANK, Department of Biopathology, Cancer Center Leon Berard, Lyon, France.
Seiki HasegawaDepartments of Thoracic Surgery and Thoracic Oncology, Hyogo College of Medicine, Hyogo, Japan.
Hedy L KindlerSection of Hematology/Oncology, University of Chicago, Chicago, Illinois.
Harvey I PassDepartment of Cardiothoracic Surgery, NYU-Langone Medical Center, New York, New York.
Valerie W RuschThoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and Advisory Board and Participating Institutions

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancerU2CCA271890 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HARVEY Ira PASS, Leopoldo Nicolas Segal · 2023 to 2026
$4.7M
NCI NIH HHS P30 CA008748NCI NIH HHS U2C CA271890
6 · The paper itself

Abstract

The International Association for the Study of Lung Cancer collaborated with the International Mesothelioma Interest Group to propose the first TNM stage classification system for diffuse pleural mesothelioma in 1995, accepted by the Union for International Cancer Control and the American Joint Committee on Cancer for the sixth and seventh edition stage classification manuals. The International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Mesothelioma Domain developed and analyzed an international registry of patients with pleural mesothelioma and updated TNM descriptors for the eighth edition of the stage classification system. To inform revisions for the forthcoming ninth edition of the TNM stage classification system, data submission was solicited for patients diagnosed between 2013 and 2022 with expanded data elements on the basis of the first project's exploratory analyses, including pleural thickness measurements, updated surgical nomenclature, and molecular markers. The resulting database consisted of a total of 3598 analyzable cases from Europe, Australia, Asia, North America, and South America, with a median age of 71 years (range: 18-99 y), 2775 (77.1%) of whom were men. With only 1310 patients (36.4%) undergoing curative-intent operations, this iteration of the database includes far more patients treated nonsurgically compared with prior. Four separate manuscripts on T, N, M, and stage groupings submitted to this journal will summarize analyses of these data and will serve collectively as the primary source of the proposed changes to the upcoming ninth edition of the pleural mesothelioma stage classification system.

Indexed as

Lung NeoplasmsMesotheliomaNeoplasm StagingPleural NeoplasmsAdolescentAdultAgedAged, 80 and overDatabases, FactualFemaleHumansMaleMesothelioma, MalignantMiddle AgedYoung AdultExtrapleural pneumonectomyMesotheliomaMesothelioma databasesPleurectomy/decorticationStagingTNM classification

Identifiers

PMID38309456
PMCPMC12063365

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.